Lecerf J-M, Lamotte C, Boukandoura B, Cayzeele A, Libersa C, Delannoy C, Borgiès B
Service de nutrition, Institut Pasteur de Lille, 1 rue du Pr Calmette, Lille cedex, France.
Eur J Clin Nutr. 2008 Jul;62(7):879-84. doi: 10.1038/sj.ejcn.1602797. Epub 2007 May 23.
BACKGROUND/OBJECTIVE: Calcium is essential for the bone metabolism but daily calcium requirements are not met in a significant proportion of the population. Fortunately, oral calcium supplementation can help to meet these needs; however, the calcium bioavailability depends on the calcium sources. The calcium absorption and bioavailability of dietary supplements from marine sources are not known. The objectives of this study were to evaluate the effects of two marine dietary supplements with a high calcium content: a fishbone powder (Phoscalim) and a ray cartilage hydrolysate (Glycollagene), in comparison with milk, and a placebo (maltodextrin), on calcium metabolism and a biochemical marker of bone resorption, using the oral calcium tolerance test.
Twenty male volunteers were randomized to eat 836 mg of calcium from different sources compared to maltodextrin during a Latin square study. Serum calcium concentrations and other parameters of the calcium metabolism, such as serum intact parathyroid hormone (iPTH) and serum C telopeptides (s-CTX), were measured after an acute oral calcium load based on the Pak protocol.
An increase in serum-corrected calcium areas under the curve (AUC) occurred with Phoscalim and Glycollagene when compared to milk. Significantly lower iPTH concentrations were observed with Glycollagene than with milk at T0+1 h, T0+3 h, T0+6 h and with Phoscalim than with milk at T0+6 h. A significantly lower s-CTX concentration was observed with Glycollagene than with milk and Phoscalim at T0+6 h. Furthermore, the urinary calcium/creatinine ratio increased significantly more with Glycollagen than with milk in T0 h+3 h and T3 h+6 h.
These two dietary supplements from marine sources constitute oral calcium sources when compared to milk on calcium absorption and bone resorption markers on short time.
背景/目的:钙对骨骼代谢至关重要,但相当一部分人群的每日钙需求量未得到满足。幸运的是,口服补钙有助于满足这些需求;然而,钙的生物利用度取决于钙源。海洋来源膳食补充剂的钙吸收和生物利用度尚不清楚。本研究的目的是使用口服钙耐量试验,评估两种高钙海洋膳食补充剂(鱼骨粉(Phoscalim)和鳐鱼软骨水解物(Glycollagene))与牛奶和安慰剂(麦芽糊精)相比,对钙代谢和骨吸收生化标志物的影响。
在拉丁方研究中随机选取20名男性志愿者,与麦芽糊精相比,食用来自不同来源的836毫克钙。根据帕克方案,在急性口服钙负荷后,测量血清钙浓度和其他钙代谢参数,如血清完整甲状旁腺激素(iPTH)和血清C端肽(s-CTX)。
与牛奶相比,Phoscalim和Glycollagene的血清校正钙曲线下面积(AUC)增加。在T0 + 1小时、T0 + 3小时、T0 + 6小时,Glycollagene的iPTH浓度显著低于牛奶,在T0 + 6小时,Phoscalim的iPTH浓度显著低于牛奶。在T0 + 6小时,Glycollagene的s-CTX浓度显著低于牛奶和Phoscalim。此外,在T0小时 + 3小时和T3小时 + 6小时,Glycollagen的尿钙/肌酐比值比牛奶显著增加更多。
与牛奶相比,这两种海洋来源的膳食补充剂在短时间内的钙吸收和骨吸收标志物方面构成口服钙源。